Filing Details
- Accession Number:
- 0001236031-20-000011
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-27 07:57:25
- Reporting Period:
- 2020-02-26
- Accepted Time:
- 2020-02-27 07:57:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 725363 | Cel Sci Corp | CVM | Biological Products, (No Disgnostic Substances) (2836) | 840916344 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1511858 | Eugene Robert Watson | 245 N. Highland Ave Ne Suite 230-296 Atlanta 2Q 30307 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-02-26 | 923 | $10.83 | 2,381 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- On February 26, 2020, Mr. Watson purchased $10,000 worth of restricted stock directly from the Company at the closing price on February 26, 2020, the most recent closing price available.
Billionaire Hedge Funds
